Victory Capital Management
ALT icon

Victory Capital Management’s Altimmune ALT Stock Holding History

Victory Capital Management’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$45.5K Buy
14,763
+2,833
+24% +$12K ﹤0.01% 2317
2025
Q4 		$43.1K Buy
11,930
+1,869
+19% +$8.15K ﹤0.01% 2342
2025
Q3 		$37.9K Buy
+10,061
New +$38.8K ﹤0.01% 2366
2020
Q2 		– Sell
-4,676
Closed -$16K – 2525
2020
Q1 		$16K Buy
+4,676
New +$10.8K ﹤0.01% 3152
2019
Q4 		– Sell
-2,325
Closed -$5K – 2649
2019
Q3 		$5K Buy
+2,325
New +$5.15K ﹤0.01% 3441

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Victory Capital Management's ALT Position: Q1 2026 in Review

Victory Capital Management increased its Altimmune (ALT) stake by 24% in Q1 2026, buying an estimated $12K and bringing the position to 14,763 shares worth $45.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2317.

Victory Capital Management first reported a position in ALT in Q3 2019 and has held it in 5 quarters since. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Victory Capital Management held 14,763 shares of Altimmune worth $45.5K as of Q1 2026.
  • Victory Capital Management bought 2,833 Altimmune shares in Q1 2026, an estimated $12K.
  • Altimmune made up ﹤0.01% of Victory Capital Management's portfolio in Q1 2026, its #2317 holding.
  • Victory Capital Management first reported a position in Altimmune in Q3 2019 and has held it in 5 quarters since.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.